technique such as 1HNMR only. The synthesized compounds were assessed for acute toxicity test and are proved free of toxicity. The derivatives were further tested as anti-inflammatory agents by in vitro lipoxygenase enzyme inhibition studies, molecular docking, and in vivo carrageenan-induced paw edema assay, and histamine-induced edema test. The overall observations presented that compounds SK1 and SK3
在目前的工作中,通过异
硫氰酸酯和二胺在干燥
丙酮中的缩合反应合成了双
硫脲衍
生物,形成SK1(1,2-bis(氮-苯甲酰
硫脲基)苯),SK2(1,3-双(氮-苯甲酰
硫脲基)苯)和SK3(1,4-双(氮-苯甲酰
硫脲基)苯)。通过熔点和光谱技术确认了新合成衍
生物的结构,例如1仅 1HNMR。合成的化合物进行了急性毒性试验,证明无毒。通过进一步测试这些衍
生物作为抗炎剂体外脂氧合酶抑制研究、分子对接和体内角叉菜胶诱导的爪
水肿试验和
组胺诱导的
水肿试验。总体观察结果表明,化合物 SK1 和 SK3 具有良好的抗炎潜力,而化合物 SK2 则被发现是一种良好的抗炎剂。